Fairfax Sells Eurolife Life Insurance Stake to Eurobank
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Fairfax Financial Holdings ( (TSE:FFH) ).
On October 13, 2025, Fairfax Financial Holdings Limited announced the sale of its 80% equity interest in the life insurance business operated by Eurolife FFH Insurance Group Holdings S.A. to Eurobank for €813 million. Fairfax will retain its 80% interest in Eurolife’s property and casualty insurance business and acquire a 45% equity interest in Eurobank’s property and casualty insurance operations in Cyprus for €59 million. This strategic move allows Fairfax to focus on its core property and casualty insurance operations while benefiting from Eurolife’s continued success under Eurobank’s ownership.
The most recent analyst rating on (TSE:FFH) stock is a Buy with a C$2792.00 price target. To see the full list of analyst forecasts on Fairfax Financial Holdings stock, see the TSE:FFH Stock Forecast page.
Spark’s Take on TSE:FFH Stock
According to Spark, TipRanks’ AI Analyst, TSE:FFH is a Outperform.
Fairfax Financial Holdings receives a strong overall score due to its robust financial performance, attractive valuation, and positive earnings call sentiment. The company’s profitability, effective equity utilization, and strategic resilience in international markets are key strengths. Technical indicators support a stable outlook, while the low P/E ratio suggests potential undervaluation.
To see Spark’s full report on TSE:FFH stock, click here.
More about Fairfax Financial Holdings
Fairfax Financial Holdings Limited is a holding company primarily engaged in property and casualty insurance and reinsurance, along with associated investment management, through its subsidiaries.
Average Trading Volume: 46,206
Technical Sentiment Signal: Buy
Current Market Cap: C$58.79B
Find detailed analytics on FFH stock on TipRanks’ Stock Analysis page.
Disclaimer & DisclosureReport an Issue
